| http://www.w3.org/ns/prov#value | - At present, Aspen Pharmacare holds a voluntary license from Gilead Sciences to market each of these drugs in sub-Saharan Africa and has so far received regulatory approval to sell tenofovir or Truvada in a dozen or so other countries including Ghana, Zambia, Ethiopia, Uganda, Kenya, Malawi, Botswana, Namibia, Rwanda, Nigeria, the Democratic Republic of the Congo, Senegal, and Tanzania.
|
